Protective effects of Guizhi-Fuling-capsules on rat brain ischemia/reperfusion injury

Journal of Pharmacological Sciences

Volumn 105, Issue 1, 2007, Pages 34-40

  Li, Tie Jun ^a   Qiu, Yan ^a   Mao, Jun Qin ^b   Yang, Peng Yuan ^a   Rui, Yao Cheng ^a   Chen, Wan Sheng ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b No 85 Hospital of PLA   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Cytokine; Inflammation; Traditional Chinese medicine

Indexed keywords

CHINESE DRUG; CINNAMOMUM CASSIA EXTRACT; GLUTAMIC ACID; GUIZHI FULING; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 1BETA; MESSENGER RNA; NITROXIDE; PAEONIA LACTIFLORA EXTRACT; PAEONIA SUFFRUTICOSA EXTRACT; PLANT EXTRACT; PORIA COCOS EXTRACT; PRUNUS PERSICA EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; BRAIN INFARCTION; BRAIN ISCHEMIA; CHINESE MEDICINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG CAPSULE; INFLAMMATION; MALE; NERVE INJURY; NONHUMAN; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; UPREGULATION; WATER CONTENT;

EID: 34648832975     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0070450     Document Type: Article

References (26)

1. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2:43-53.
2. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol. 2000;10:95-112.
3. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2:734-744.
4. Iadecola C, Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol. 2001;14:89-94.
5. Gong X, Sucher NJ. Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development. Trends Pharmacol Sci. 1999;20:191-196.
6. Kim H. Neuroprotective herbs for stroke therapy in traditional eastern medicine. Neurol Res. 2005;27:287-301.
7. Goto H, Shimada Y, Sekiya N, Yang Q, Kogure T, Mantani N, et al. Effects of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats. Phytomedicine. 2004;11:188-195.
8. Sekiya N, Tanaka N, Itoh T, Shimada Y, Goto H, Terasawa K. Keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesterol-fed rabbit. Phytother Res. 1999;13:192-196.
9. Sekiya N, Kainuma M, Hikiami H, Nakagawa T, Kouta K, Shibahara N, et al. Oren-gedoku-to and Keishi-bukuryo-gan-ryo inhibit the progression of atherosclerosis in diet-induced hypercholesterolemic rabbits. Biol Pharm Bull. 2005;28:294-298.
10. Shimada Y, Yokoyama K, Goto H, Sekiya N, Mantani N, Tahara E, et al. Protective effect of keishi-bukuryo-gan and its constituent medicinal plants against nitric oxide donor-induced neuronal death in cultured cerebellar granule cells. Phytomedicine. 2004;11:404-410.
11. Goto H, Shimada Y, Mitsuma T, Shintani T, Nagasaka K, Goto S, et al. Effect of Keishi-bukuryo-gan on asymptomatic cerebral infarction for short term. J Trad Med. 2002;19:46-50.
12. Hikiami H, Kohta K, Sekiya N, Shimada Y, Itoh T, Terasawa K. Erythrocyte deformability in "oketsu" syndrome and its relations to erythrocyte viscoelasticity. J Trad Med. 1996;13:156-164.
13. Kohta K, Hikiami H, Shimada Y, Matsuda H, Hamazaki T, Terasawa K. Effects of Keishi-bukuryo-gan on erythrocyte aggregability in patients with multiple old lacunar infarction. J Med Pharm Soc WAKAN-YAKU. 1993;10:251-259.
14. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84-91.
15. 2+ and amino acids in rats with cerebral ischemia and reperfusion.] Zhongguo Zhong Yao Za Zhi. 1998;23:558-559. (text in Chinese with English abstract in back cover)
16. Saito K, Suyama K, Nishida K, Sei Y, Basile AS. Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett. 1996;206:149-152.
17. Zhai QH, Futrell N, Chen FJ. Gene expression of IL-10 in relationship to TNF-alpha, IL-1beta and IL-2 in the rat brain following middle cerebral artery occlusion. J Neurol Sci. 1997;152:119-124.
18. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, et al. Tumor necrosis factor-alpha, A mediator of focal ischemic brain injury. Stroke. 1997;28:1233-1244.
19. Loddick SA, Rothwell NJ. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab. 1996;16:932-940.
20. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke. 1995;26:676-680; discussion 681.
21. Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett. 1998;251:189-192.
22. Ooboshi H, Ibayashi S, Shichita T, Kumai Y, Takada J, Ago T, et al. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation. 2005;111:913-919.
23. Storini C, Rossi E, Marrella V, Distaso M, Veerhuis R, Vergani C, et al. C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation. Neurobiol Dis. 2005;19:10-17.
24. Kim KY, Kim MY, Choi HS, Jin BK, Kim SU, Lee YB. Thrombin induces IL-10 production in microglia as a negative feedback regulator of TNF-alpha release. Neuroreport. 2002;13:849-852.
25. Bachis A, Colangelo AM, Vicini S, Doe PP, De Bernardi MA, Brooker G, et al. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci. 2001;21:3104-3112.
26. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med. 1999;5:554-559.